About Gri Bio (GRI)
GRI Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a pipeline of Natural Killer T (NKT) modulating therapies for the treatment of inflammatory, fibrotic and autoimmune diseases. The Company's lead program, GR... Read more
- USD1.70
- USD1.87
- USD1.60
- USD106.04
- -79.30%
- --
- 248.17k
- 1.15M
- 1M
- 1.10
- -98.30%
Stock News
yesterday
Where Trump’s tariffs and economic promises stand as he nears 100 days in office
MarketWatch
yesterday
Why Universal Logistics (ULH) Stock Is Down Today
Yahoo
yesterday
38-year-old turned his New York apartment into a 'spice warehouse'—now his company brings in $8 million a year
CNBC
yesterday
We're putting a big weekly winner in the Bullpen but see more room for the stock to run
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
